Bodo Haas

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Topics

Postoperative Pain

Epithelial Mesenchymal Transition

Tyrosine Kinase

Cell Cycle Arrest

Top Venues

International journal of molecular sciences

Journal of cancer research and clinical oncology

Cancer cell international

Federal Institute for Drugs and Medical Devices

Ludwig-Maximilians-Universität München (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Federal Institute for Drugs and Medical Devices Nov 01 2010

Germany

Toxicologist / Research Group leader :: Genetic and Reproductive Toxicology

University of Bonn

Germany

PostDoc :: Pharmacology and Toxicology

Education History

Ludwig-Maximilians-Universität München

Germany

PHD :: Pharmacology

Publications

Bodo Haas, Janine Ciftcioglu, Sanja Jermar, Sandra Weickhardt, Niels Eckstein, Bernd Kaina
Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent. Journal of cancer research and clinical oncology 147 (3) (2020)
Bernd Kaina, Lea Beltzig, Andrea Piee-Staffa, Bodo Haas
Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells. International journal of molecular sciences 21 (19) (2020)
Bodo Haas, Veronika Klinger, Christina Keksel, Verena Bonigut, Daniela Kiefer, Julia Caspers, Julia Walther, Maria Wos-Maganga, Sandra Weickhardt, Gabriele Röhn, Marco Timmer, Roland Frötschl, Niels Eckstein
Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs. Cancer cell international 18 (2018)
Bodo Haas, Lena Schütte, Maria Wos-Maganga, Sandra Weickhardt, Marco Timmer, Niels Eckstein
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells. International journal of molecular sciences 19 (10) (2018)